Drug development company Acelyrin Inc. recently saw a modest increase in its stock price after announcing the adoption of a ...

Poison oak rash is an allergic reaction to the leaves or stems of the western poison oak plant (Toxicodendron diversilobum). Home remedies and medical treatments can help manage symptoms. The ...

Both Pliant and Acelyrin have implemented their own “poison pill” plans. The rule changes mean that if a single investor secures 10% or more of either company’s stock, it will trigger ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter.

Today, a brief rundown of news involving Martin Makary, as well as updates from Pliant Therapeutics, Acelyrin and Sutro Biopharma that you may have missed. Over the past 10 years, PD1-blocking ...

If you currently take or have taken birth control pills in the recent past, you are slightly more likely to develop breast cancer than women who've never used them. Fortunately, research shows that ...

LOS ANGELES - Acelyrin Inc. (NASDAQ: SLRN), a biopharmaceutical company specializing in immunology treatments, has implemented a stockholder rights plan following Tang Capital Partners’ acquisition of ...

Information about ACELYRIN’s directors and executive officers is set forth in the proxy statement for ACELYRIN’s 2024 Annual Meeting of Stockholders, which was filed with the SEC on April 22 ...

Pliant and Acelyrin adopt poison pill measures to counter activist investor Kevin Tang's stock accumulation, aiming to ...

The move by Acelyrin’s board comes as the venture capital firm has taken larger and larger stakes in the company in an attempt to disrupt a merger with Alumis.